Preclinical Models of Pancreatic Ductal Adenocarcinoma and Their Utility in Immunotherapy Studies

SIMPLE SUMMARY: Immune checkpoint blockade has provided durable clinical responses in a number of human malignancies, but not in patients with pancreatic cancer. Efforts to understand mechanisms of resistance and increase efficacy of immune checkpoint blockade in pancreatic cancer require the use of...

Descripción completa

Detalles Bibliográficos
Autores principales: Pham, Thao N. D., Shields, Mario A., Spaulding, Christina, Principe, Daniel R., Li, Bo, Underwood, Patrick W., Trevino, Jose G., Bentrem, David J., Munshi, Hidayatullah G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865443/
https://www.ncbi.nlm.nih.gov/pubmed/33503832
http://dx.doi.org/10.3390/cancers13030440

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865443/
https://www.ncbi.nlm.nih.gov/pubmed/33503832
http://dx.doi.org/10.3390/cancers13030440

Ejemplares similares